Corbus Pharmaceuticals Holdings, Inc.
100 River Ridge Drive
Norwood, MA 02062
United States - Map
Phone: 617-963-0100
Fax: 617-663-6085
Website: http://www.corbuspharma.com
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Recent Headlines
Tuesday's Rally Was Driven Mostly by Technical Conditions
News that the Senate was close to agreeing on a border deal that would avert a second government shutdown received the credit for a fast and furious rally today. The momentum slowed in the afternoon and there was no ramp up in the last 45 minutes for the first time in 15 sessions, but there were no notable pullbacks during the day.
It's a Stock Picker's Delight Right Now
It is still unclear if that deal will happen, but market players were not well-positioned for upside on Tuesday morning and now they are scrambling to put some cash to work. This stock has no analyst coverage and the story is still not very well-known.
Corbus Pharmaceuticals (CRBP) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Corbus Pharmaceuticals (CRBP) closed at $7.64, marking a -0.52% move from the previous day.
Should Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Be Your Next Stock Pick?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is aRead More...
Top Marijuana Stocks on the NASDAQ
Although the majority of U.S.-based cannabis companies and many foreign ADRs trade over-the-counter, a few marijuana companies are traded on the NASDAQ. Some investors prefer stocks that are listed on the NASDAQ to other exchanges due to their increased liquidity and tighter spreads than the OTC markets.
NEW YORK, Feb. 05, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
HENDERSON, NV / ACCESSWIRE / January 31, 2019 / With the IBB getting set to cap off its most bullish month in a while, the biotech industry could be in store for a major renaissance in 2019. Below are ...
Norwood, MA, Jan. 30, 2019 -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company), a clinical stage drug development company with the industry’s.
Jim Cramer Shares His Predictions For The Cannabis Industry
On CNBC's "Mad Money" Monday, Jim Cramer spoke about the future of the cannabis industry. The sector traded higher on Monday on no real news, so Cramer said he can't recommend cannabis stocks as a buy. It will be possible to buy the equities at a cheaper price, the CNBC host said, adding that he still believes that legalized marijuana is one of the greatest growth stories of the era.
Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Corbus Pharmaceuticals Holdings, Inc. (CRBP) (“Corbus” or the “Company), a clinical stage drug development company with the industry’s leading pipeline focused on treating inflammatory and fibrotic diseases through the endocannabinoid system pathways, today announced the pricing of an underwritten public offering of 5,390,000 shares of its common stock at a public offering price of $6.50 per share, for a total public offering size of approximately $35 million, before deducting underwriting discounts and estimated offering expenses. In addition, Corbus has granted the underwriters a 30-day option to purchase up to an additional 808,500 shares of its common stock on the same terms and conditions. Corbus intends to use the net proceeds of the proposed underwritten offering to fund its continued development of lenabasum and the compounds recently licensed from Jenrin and for general corporate purposes, which may include funding preclinical studies and clinical trials, manufacturing lenabasum and the Jenrin compounds for clinical trials and commercial launch, and acquisitions or investments in businesses, products or technologies that are complementary, and to increase its working capital and fund capital expenditures.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Research Links
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) Stock Message Board
| 6 | 53% 17.8M C7.95 H 8.3 S@6.86 good solid | znewcar1 | 09/20/2018 4:09:12 PM |
| 5 | WTH is going on with this stock? Naked shorts? | LeaveMeAlone | 04/06/2017 2:10:15 PM |
| 4 | PowerPoint Presentation of March 8, 2017 | Triple9 | 03/08/2017 8:53:29 AM |
| 3 | $CRBP biotech drug pipeline solid. This will be a | MicroCapStocksRock | 11/30/2016 8:28:26 AM |
| 2 | February 8-9, 2016 The Waldorf Astoria New York | BooDog | 01/23/2016 1:15:00 PM |
| 1 | Share Statistics Avg Vol (3 month)3: 902,242 Avg | BooDog | 09/22/2015 3:06:52 PM |
